Viewing Study NCT00949351

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-01-07 @ 7:11 AM
Study NCT ID: NCT00949351
Status: UNKNOWN
Last Update Posted: 2009-07-30
First Post: 2009-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy
Sponsor: Lerdsin General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes With Nephropathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ACEI, ARB, DN, aliskiren, proteinuria View